- Home
- Appointees
- Anne Sokolov
Anne Sokolov
Official, Office of National Drug Control Policy · 2021
Anne Sokolov, an official at the Office of National Drug Control Policy, received a certificate of divestiture from the Office of Government Ethics, which lets an official sell holdings that would create a conflict of interest and defer the capital gains tax. 1 filing with the Office of Government Ethics, most recently Apr 20, 2021.
- Agency
- Office of National Drug Control Policy
- Ethics filings
- 1
- Latest filing
- Apr 20, 2021
Financial disclosure and ethics filings
- Certificate of Divestiture OGE-2021-051Apr 20, 2021
Filed with the U.S. Office of Government Ethics. Form 278 reports list assets, income and debts; ethics agreements list what the official promised to sell or step away from.
More officials at the Office of National Drug Control Policy
- Michael Passante DAEO
- Rahul Gupta Director
- Anthony D Jones DAEO
More
From Senate roll call votes, Wikidata, Wikipedia and Office of Government Ethics records.
Cite or embed this page
Capitol Receipts, “Anne Sokolov, Office of National Drug Control Policy: Ethics Filings,” https://www.capitolreceipts.com/appointee/osokolovanne/anne-sokolov (accessed 2026-10-13).